For Researchers
M. Vatic, S. von Haehling, N. EbnerExp Gerontol. 2020;133:110858. doi: 10.1016/j.exger.2020.110858. Epub 2020 Jan 31. This review summarizes the present knowledge of inflammatory biomarkers that are considered promising tools to evaluate frailty. |
L. Rodriguez-Mañas, I. Araujo de Carvalho, S. Bhasin,et al.J Frailty Aging. 2020;9(1):4-8. doi: 10.14283/jfa.2019.32. The International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force - a group of academic and industry scientists from around the world -- met in February 2019 to discuss the current state of biomarker development for frailty and sarcopenia. |
Y. Osuka, H. Kim, H. Kawai,et al.J Clin Med. 2020;9(3). pii: E692. doi: 10.3390/jcm9030692. We developed an index for assessing sarcopenia degree (sarcoscore) and compared it to the Asian Working Group for Sarcopenia (AWGS) criteria. |
G.J Grosicki, B.B. Barrett, D.A. Englund,et al.J Frailty Aging. 2020;9(1):57-63. doi: 10.14283/jfa.2019.30. The aim was to investigate relationships between circulating IL-6, skeletal muscle health and exercise adaptation in mobility-limited older adults. |
S. Bhasin, T.G. Travison, T.M. Maniniz, et al.J Am Geriatr Soc. 2020 Mar 9. doi: 10.1111/jgs.16372. [Epub ahead of print] The aim was to develop an evidence-based definition of sarcopenia that can facilitate identification of older adults at risk for clinically relevant outcomes (eg, self-reported mobility limitation, falls, fractures, and mortality), the Sarcopenia Definition and Outcomes Consortium (SDOC) crafted a set of position statements informed by a literature review and SDOC's analyses of eight epidemiologic studies, six randomized clinical trials, four cohort studies of special populations, and two nationally representative population-based studies. |
R.J. Gobbens, P. Boersma, I. Uchmanowicz, et al.Clin Interv Aging. 2020;15:265-274 The Tilburg Frailty Indicator (TFI) is a self-report user-friendly questionnaire for assessing multidimensional frailty among community-dwelling older people. The main aim of this study is to re-evaluate the validity of the TFI, both cross-sectionally and longitudinally, focusing on the predictive value of the total TFI and its physical, psychological, and social domains for adverse outcomes disability, indicators of healthcare utilization, and falls. |